Genetically controlled mtDNA deletions prevent ROS damage by arresting oxidative phosphorylation

  1. Simon Stenberg
  2. Jing Li
  3. Arne B Gjuvsland
  4. Karl Persson
  5. Erik Demitz-Helin
  6. Carles González Peña
  7. Jia-Xing Yue
  8. Ciaran Gilchrist
  9. Timmy Ärengård
  10. Payam Ghiaci
  11. Lisa Larsson-Berghund
  12. Martin Zackrisson
  13. Silvana Smits
  14. Johan Hallin
  15. Johanna L Höög
  16. Mikael Molin
  17. Gianni Liti
  18. Stig W Omholt  Is a corresponding author
  19. Jonas Warringer  Is a corresponding author
  1. University of Gothenburg, Sweden
  2. Sun Yat-sen University Cancer Center, China
  3. Norwegian University of Life Sciences, Norway
  4. University of Gothenburg, Spain
  5. Chalmers University of Technology, Sweden
  6. Université Côte d'Azur, CNRS, INSERM, IRCAN, France

Abstract

Deletion of mitochondrial DNA in eukaryotes is currently attributed to rare accidental events associated with mitochondrial replication or repair of double-strand breaks. We report the discovery that yeast cells arrest harmful intramitochondrial superoxide production by shutting down respiration through genetically controlled deletion of mitochondrial oxidative phosphorylation genes. We show that this process critically involves the antioxidant enzyme superoxide dismutase 2 and two-way mitochondrial-nuclear communication through Rtg2 and Rtg3. While mitochondrial DNA homeostasis is rapidly restored after cessation of a short-term superoxide stress, long-term stress causes maladaptive persistence of the deletion process, leading to complete annihilation of the cellular pool of intact mitochondrial genomes and irrevocable loss of respiratory ability. This shows that oxidative stress-induced mitochondrial impairment may be under strict regulatory control. If the results extend to human cells, the results may prove to be of etiological as well as therapeutic importance with regard to age-related mitochondrial impairment and disease.

Data availability

Sequence data that support the findings of this study have been deposited in Sequencing Read Archive (SRA) with the accession codes PRJNA622836.The growth phenotyping code can be found at https://github.com/Scan-o-Matic/scanomatic.git, the simulation code at https://github.com/HelstVadsom/GenomeAdaptation.git and the imaging code at https://github.com/CamachoDejay/SStenberg_3Dyeast_tools.The authors declare that all other data supporting the findings of this study are available within the paper as Supplemental Information Data S1-S30, which can be previewed at https://data.mendeley.com/datasets/mvx7t7rw2d/draft?a=95381e47-dc80-47af-85ab-e0478912a209.

The following data sets were generated

Article and author information

Author details

  1. Simon Stenberg

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  2. Jing Li

    State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Arne B Gjuvsland

    Department of Animal and Aquacultural Sciences, Norwegian University of Life Sciences, Ås, Norway
    Competing interests
    The authors declare that no competing interests exist.
  4. Karl Persson

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  5. Erik Demitz-Helin

    Department of Chemistry and Molecular Biology, University of Gothenburg, erikdemitzhelin, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  6. Carles González Peña

    Department of Chemistry and Molecular Biology, University of Gothenburg, Argentona, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7771-7988
  7. Jia-Xing Yue

    State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2122-9221
  8. Ciaran Gilchrist

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  9. Timmy Ärengård

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  10. Payam Ghiaci

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  11. Lisa Larsson-Berghund

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  12. Martin Zackrisson

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  13. Silvana Smits

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  14. Johan Hallin

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  15. Johanna L Höög

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2162-3816
  16. Mikael Molin

    Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3903-8503
  17. Gianni Liti

    Institute for Research on Cancer and Aging, Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2318-0775
  18. Stig W Omholt

    Department of Animal and Aquacultural Sciences, Norwegian University of Life Sciences, Ås, Norway
    For correspondence
    Stig.omholt@ntnu.no
    Competing interests
    The authors declare that no competing interests exist.
  19. Jonas Warringer

    Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden
    For correspondence
    jonas.warringer@cmb.gu.se
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6144-2740

Funding

Vetenskapsrådet (2014-6547)

  • Jonas Warringer

Agence Nationale de la Recherche (ANR-13-BSV6-0006-01)

  • Gianni Liti

Agence Nationale de la Recherche (ANR-15-IDEX-01)

  • Gianni Liti

Agence Nationale de la Recherche (ANR-16-CE12-0019)

  • Gianni Liti

Agence Nationale de la Recherche (ANR-18-CE12-0004)

  • Gianni Liti

Human Frontiers Science Program (LT000182/2019-L)

  • Johan Hallin

Vetenskapsrådet (2014-4605)

  • Jonas Warringer

Vetenskapsrådet (2015-05427)

  • Mikael Molin

Vetenskapsrådet (2018-03638)

  • Mikael Molin

Vetenskapsrådet (2018-03453)

  • Johanna L Höög

Cancerfonden (2017-778)

  • Mikael Molin

Norges Forskningsråd (178901/V30)

  • Stig W Omholt

Norges Forskningsråd (222364/F20)

  • Stig W Omholt

Agence Nationale de la Recherche (ANR-11-LABX-0028-01)

  • Gianni Liti

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Stenberg et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,751
    views
  • 795
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Simon Stenberg
  2. Jing Li
  3. Arne B Gjuvsland
  4. Karl Persson
  5. Erik Demitz-Helin
  6. Carles González Peña
  7. Jia-Xing Yue
  8. Ciaran Gilchrist
  9. Timmy Ärengård
  10. Payam Ghiaci
  11. Lisa Larsson-Berghund
  12. Martin Zackrisson
  13. Silvana Smits
  14. Johan Hallin
  15. Johanna L Höög
  16. Mikael Molin
  17. Gianni Liti
  18. Stig W Omholt
  19. Jonas Warringer
(2022)
Genetically controlled mtDNA deletions prevent ROS damage by arresting oxidative phosphorylation
eLife 11:e76095.
https://doi.org/10.7554/eLife.76095

Share this article

https://doi.org/10.7554/eLife.76095

Further reading

    1. Cell Biology
    Jessica Y Chotiner, N Adrian Leu ... P Jeremy Wang
    Research Article

    Meiotic progression requires coordinated assembly and disassembly of protein complexes involved in chromosome synapsis and meiotic recombination. Mouse TRIP13 and its ortholog Pch2 are instrumental in remodeling HORMA domain proteins. HORMAD proteins are associated with unsynapsed chromosome axes but depleted from the synaptonemal complex (SC) of synapsed homologs. Here we report that TRIP13 localizes to the synapsed SC in early pachytene spermatocytes and to telomeres throughout meiotic prophase I. Loss of TRIP13 leads to meiotic arrest and thus sterility in both sexes. Trip13-null meiocytes exhibit abnormal persistence of HORMAD1 and HOMRAD2 on synapsed SC and chromosome asynapsis that preferentially affects XY and centromeric ends. These major phenotypes are consistent with reported phenotypes of Trip13 hypomorph alleles. Trip13 heterozygous mice exhibit meiotic defects that are less severe than the Trip13-null mice, showing that TRIP13 is a dosage-sensitive regulator of meiosis. Localization of TRIP13 to the synapsed SC is independent of SC axial element proteins such as REC8 and SYCP2/SYCP3. Terminal FLAG-tagged TRIP13 proteins are functional and recapitulate the localization of native TRIP13 to SC and telomeres. Therefore, the evolutionarily conserved localization of TRIP13/Pch2 to the synapsed chromosomes provides an explanation for dissociation of HORMA domain proteins upon synapsis in diverse organisms.

    1. Cell Biology
    Johanna Odenwald, Bernardo Gabiatti ... Susanne Kramer
    Research Article

    Immunofluorescence localises proteins via fluorophore-labelled antibodies. However, some proteins evade detection due to antibody-accessibility issues or because they are naturally low abundant or antigen density is reduced by the imaging method. Here, we show that the fusion of the target protein to the biotin ligase TurboID and subsequent detection of biotinylation by fluorescent streptavidin offers an ‘all in one’ solution to these restrictions. For all proteins tested, the streptavidin signal was significantly stronger than an antibody signal, markedly improving the sensitivity of expansion microscopy and correlative light and electron microscopy. Importantly, proteins within phase-separated regions, such as the central channel of the nuclear pores, the nucleolus, or RNA granules, were readily detected with streptavidin, while most antibodies failed. When TurboID is used in tandem with an HA epitope tag, co-probing with streptavidin and anti-HA can map antibody-accessibility and we created such a map for the trypanosome nuclear pore. Lastly, we show that streptavidin imaging resolves dynamic, temporally, and spatially distinct sub-complexes and, in specific cases, reveals a history of dynamic protein interaction. In conclusion, streptavidin imaging has major advantages for the detection of lowly abundant or inaccessible proteins and in addition, provides information on protein interactions and biophysical environment.